Tempus AI (NASDAQ:TEM) Shares Up 4% – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM) shares shot up 4% during mid-day trading on Wednesday . The company traded as high as $48.29 and last traded at $47.57. 3,538,763 shares changed hands during trading, a decline of 29% from the average session volume of 4,976,978 shares. The stock had previously closed at $45.74.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on TEM. Needham & Company LLC lifted their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a report on Tuesday, February 25th. Loop Capital cut their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Wolfe Research downgraded shares of Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Tempus AI currently has an average rating of “Moderate Buy” and an average target price of $61.18.

Tempus AI Trading Up 3.1 %

The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The company has a 50-day moving average price of $55.65 and a two-hundred day moving average price of $51.50.

Insider Transactions at Tempus AI

In related news, CAO Ryan M. Bartolucci sold 13,770 shares of the firm’s stock in a transaction on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the sale, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at $3,434,220. This trade represents a 19.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Ryan Fukushima sold 20,000 shares of the company’s stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $39.61, for a total transaction of $792,200.00. Following the completion of the transaction, the chief operating officer now owns 982,442 shares of the company’s stock, valued at $38,914,527.62. This trade represents a 2.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,561,814 shares of company stock valued at $315,485,164.

Institutional Investors Weigh In On Tempus AI

A number of institutional investors have recently made changes to their positions in the company. Operose Advisors LLC bought a new position in Tempus AI during the 4th quarter valued at about $25,000. First Horizon Advisors Inc. bought a new position in Tempus AI during the third quarter valued at approximately $30,000. Farther Finance Advisors LLC purchased a new stake in Tempus AI in the fourth quarter worth approximately $34,000. Prestige Wealth Management Group LLC boosted its holdings in Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after purchasing an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC bought a new stake in Tempus AI in the 4th quarter worth approximately $49,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.